Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
11.75
-0.08 (-0.68%)
Dec 12, 2025, 4:00 PM EST - Market closed
Avanos Medical Market Cap
Avanos Medical has a market cap or net worth of $545.42 million as of December 12, 2025. Its market cap has decreased by -38.73% in one year.
Market Cap
545.42M
Enterprise Value
608.62M
1-Year Change
-38.73%
Ranking
Category
Stock Price
$11.75
Market Cap Chart
Since October 21, 2014, Avanos Medical's market cap has decreased from $1.91B to $545.42M, a decrease of -71.41%. That is a compound annual growth rate of -10.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 549.10M | -24.95% |
| Dec 31, 2024 | 731.60M | -29.74% |
| Dec 29, 2023 | 1.04B | -17.24% |
| Dec 30, 2022 | 1.26B | -24.69% |
| Dec 31, 2021 | 1.67B | -23.88% |
| Dec 31, 2020 | 2.19B | 35.87% |
| Dec 31, 2019 | 1.62B | -23.97% |
| Dec 31, 2018 | 2.12B | -1.78% |
| Dec 29, 2017 | 2.16B | 25.31% |
| Dec 30, 2016 | 1.73B | 10.83% |
| Dec 31, 2015 | 1.56B | -26.40% |
| Dec 31, 2014 | 2.12B | 10.90% |
| Oct 21, 2014 | 1.91B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |